Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Clinical trial NCT02817945 · UNKNOWN

Trial details

NCT number: NCT02817945
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Lung Cancer Neuroendocrine Neoplasm

Start date: 2016-06-01
Primary completion: 2020-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.